Press release
Celiac Disease Market Outlook 2031 Features Growth in Oral and Parenteral Treatment Routes and Increasing Homecare Adoption
Celiac Disease Market
The Global Celiac Disease Market is estimated to reach over USD 1,195.5 Mn by 2031, exhibiting a CAGR of 9.8% during the forecast period.
Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/2874
Celiac disease is a chronic autoimmune disorder precipitated by the ingestion of gluten, a protein present in wheat, rye, and barley. Upon gluten exposure, the immune system initiates an inflammatory response that damages the lining of the small intestine, specifically the villi, which are essential for nutrient absorption. This damage impairs the body's ability to absorb key nutrients-such as proteins, fats, carbohydrates, vitamins, and minerals-potentially leading to malnutrition if left untreated.
The global celiac disease market is witnessing significant growth, fueled by rising disease prevalence, increasing public awareness, and continuous advancements in diagnostic technologies. Notable market trends include higher diagnosis rates, the proliferation of gluten-free food products, and ongoing research into targeted therapeutic interventions. Key growth drivers encompass improved diagnostic accuracy, growing adoption of gluten-free dietary habits, and expanding availability of disease-specific solutions.
Despite this positive trajectory, the market encounters several obstacles, such as underdiagnosis, limited public knowledge, and stringent regulatory frameworks governing gluten-free product labeling and compliance. Market segmentation by diagnostic modality, treatment type, end-user profile, and geographical distribution facilitates the implementation of focused commercial strategies. To meet the evolving needs of this patient population, stakeholders have opportunities to invest in the development of advanced diagnostics, innovative treatment modalities, and high-quality gluten-free alternatives. With increasing global awareness and a rising emphasis on disease management, the celiac disease market is expected to continue its upward momentum.
List of Prominent Players in the Celiac Disease Market:
• Amgen
• Anokion SA
• BioLineRx Ltd
• ChemoCentryx, Inc
• COUR Pharmaceutical
• F. Hoffmann-La Roche Ltd
• ImmunogenX, LLC
• Innovate Biopharmaceuticals
• Takeda Pharmaceutical Company Limited
• Teva Pharmaceutical Industries Ltd.
Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-03
Market Dynamics
Drivers:
The growth of the global celiac disease market is primarily driven by the increasing prevalence of the condition, which has led to heightened demand for gluten-free dietary products and therapeutic interventions. Rising consumer awareness regarding the health implications of gluten consumption is further accelerating market expansion. While many individuals receive formal diagnoses, a significant portion of the population is adopting gluten-free diets due to greater public understanding of gluten sensitivity and its associated risks. In addition, advancements in diagnostic methodologies have facilitated earlier and more accurate identification of celiac disease, contributing to a growing diagnosed patient base. The expanded availability of gluten-free options across retail and foodservice sectors has also supported adherence to prescribed dietary regimens, further propelling market growth.
Challenges:
Despite favorable growth prospects, the market faces several challenges that may restrict its advancement. The elevated cost of gluten-free products remains a considerable barrier, limiting accessibility for some patient populations. Persistent underdiagnosis, particularly in regions with low disease awareness, continues to hinder comprehensive disease management. Moreover, compliance with stringent food labeling and safety regulations presents operational complexities for gluten-free product manufacturers. In emerging markets, limited distribution infrastructure and product availability also constrain market penetration and affect patient adherence to gluten-free dietary requirements.
Regional Trends:
North America currently holds the largest share of the celiac disease market, supported by a high prevalence of the condition, robust healthcare expenditure, and the presence of leading market participants. The United States is the key contributor to regional growth. Meanwhile, the Asia-Pacific region is projected to exhibit a strong compound annual growth rate (CAGR) through 2032, fueled by increasing awareness, improved healthcare infrastructure, and expanding population bases. Within this region, China accounts for the highest market share, while India is emerging as the fastest-growing market, driven by rising diagnosis rates and increased consumer health consciousness.
Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/2874
Recent Developments:
• In June 2021, BioLineRx announced the start of a Phase 2b clinical trial for its flagship drug, BL-7010, as a therapy for celiac disease. The experiment will assess the safety and efficacy of BL-7010 in lowering gluten-induced symptoms and gut inflammation in celiac disease patients.
• In September 2022, ChemoCentryx recently announced encouraging results from a Phase 2 clinical trial of a new medication candidate for celiac disease-associated refractory sprue. The study found that refractory sprue, a severe form of celiac disease, showed encouraging results in terms of symptom reduction and intestinal health.
Segmentation of Celiac Disease Market-
By Treatments-
• Infliximab
• Larazotide Acetate
• Gluten-Free Diet
• Others
By Route of Administration-
• Oral
• Parenteral
By End-Users-
• Hospitals
• Homecare
• Others
By Distribution Channels-
• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of the Middle East and Africa
Read Overview Report- https://www.insightaceanalytic.com/report/celiac-disease-market/2874
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 607 400-7072
Asia: +91 79 72967118
info@insightaceanalytic.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Celiac Disease Market Outlook 2031 Features Growth in Oral and Parenteral Treatment Routes and Increasing Homecare Adoption here
News-ID: 4072189 • Views: …
More Releases from Insightace Analytic Pvt Ltd.
Oral Proteins and Peptides Market Top Players - AstraZeneca, Biocon Chiasma, Nov …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Oral Proteins and Peptides Market"-, By Type of Target Disease Indication (Acromegaly, Celiac Disease, Chronic Idiopathic Constipation, Enteric Hyperoxaluria, Inflammatory Bowel Disease, and Type II Diabetes), Type of Molecule (Protein and Peptide), Type of Biological Target (GC-C, Insulin Receptor, Oxalate and others), Type of Mechanism of Action (Receptor Stimulation, Substrate Degradation and Others), and Global Forecasts,…
VEGFR-1 Inhibitors Market Know the Scope and Trends
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global VEGFR-1 Inhibitors Market- (By Drug Type (Monoclonal Antibodies, Tyrosine Kinase Inhibitors, and Others), By Application (Renal Cell Carcinoma, Colorectal Cancer, Non-Small Cell Lung Cancer, and Other), Distribution Channel (Hospital Pharmacies, Retail Pharmacies and Online Pharmacies)), By Region, Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the latest research by InsightAce Analytic, the Global…
Activated Carbon Fiber market Revenue Report with Forecast to 2031
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Activated Carbon Fiber Market Size, Share & Trends Analysis Report By Type (PAN-based, Pitch-based, Cellulosic Fiber, Phenolic Resin), Application (Solvent Recovery, Air Purification, Water Treatment, Catalyst Carrier)- Market Outlook And Industry Analysis 2031"
The global activated carbon fiber market is estimated to reach over USD 500.04 million by 2031, exhibiting a CAGR of 7.81%…
Fibrotic Diseases Treatment Market Top Companies Study - AbbVie Inc., Gilead Sci …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Fibrotic Diseases Treatment Market - (By Treatment (Medication, Organ Transplantation, Oxygen Therapy, and Others), Application (Idiopathic Pulmonary Fibrosis, Hepatic Cirrhosis, Renal Fibrosis, Cutaneous Fibrosis, and Others), End User (Hospitals, Specialty Clinics, Academic and Research Institutes, and Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to…
More Releases for Celiac
Celiac Disease Drugs Market (2020-2027) Challenges and New Trends
Celiac Disease Drugs Market report analyses the prospects in the market for several shareholders and aspirants by identifying the high-growth segments, main actions approved by them and Celiac Disease Drugs market recent progressions. The Celiac Disease Drugs market report is prepared after fundamental levels of research regarding the Celiac Disease Drugs Industry.
Celiac Disease Drugs Market by Drugs (First Line of Treatment and Second Line of Treatment) - Global Opportunity Analysis…
Global Celiac Disease Market analysis 2018 and forecasts to 2023
Global Celiac Disease Industry
New Study on “2018-2023 Celiac Disease Market Global Key Player, Demand, Growth, Opportunities and Analysis Forecast” added to Wise Guy Reports Database
Celiac disease market is an autoimmune disorder caused by the exposure to dietary gluten and damage inner lining of the small intestine. The disease can contribute to several diseases and disorders such as neurological disorder, infertility, low bone density, and certain cancers. There are presently no…
Celiac Drugs Market Projected to Grow Steadily During 2015-2021
Celiac disease, also known as celiac sprue or gluten-sensitive enteropathy, is a genetic autoimmune disorder caused due to the body’s inability to process gluten that causes damage to the small intestine. Gluten, a protein found in wheat, barley, and rye, can damage the lining of the small intestine which makes it difficult for the body to absorb nutrients such as iron, fat, calcium, and folate. The immune system mistakes substances…
Celiac Disease Drugs Market - Global Industry Analysis 2025
Celiac disease is an autoimmune disorder that mainly affects the small intestine. It is mainly observed in individual who are hereditarily inclined towards gluten. Celiac disease symptoms include gastrointestinal malfunction such as diarrhoea, abdominal distention, loss of appetite, and among kids failure to grow normally and also sometime loss of lymphocytes. Coeliac disease is triggered by a bodily reaction to gluten, generally found in wheat and in other grains such…
Celiac Disease industry analysis and forecast to 2022
The Global Celiac Disease Market Research Report provides detailed analysis of the key regional market status of the Celiac Disease Industry.
In this report, the global Celiac Disease market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
Global Celiac Disease market competition by top manufacturers/players, with Celiac Disease sales…
Celiac Disease Market 2023: Opportunity Analysis and Forecast
"The Report OpportunityAnalyzer: Celiac Disease - Opportunity Analysis and Forecast to 2023 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz"
About Celiac Disease Market
There are no pharmacological treatments that are indicated for celiac disease and the current standard of care treatment involves a gluten free diet (GFD). Steroids and immunosuppressants are used to reduce symptoms in severe cases, targeting approximately 5%…
